The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
Abstract Metformin-treated diabetics (MTD) showed a decrease in cobalamin, a rise in homocysteine, and methylmalonic acid, leading to accentuated diabetic peripheral neuropathy (DPN). This study aimed to determine whether or not metformin is a risk factor for DPN. We compared MTD to non-metformin-tr...
Guardado en:
Autores principales: | Manal Mohammed Hashem, Ahmed Esmael, Abdelfattah Kasem Nassar, Mohammed El-Sherif |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f2eb751760e4a0dab4c6df1f3f332c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence and Clinical Significance of Subclinical Hypothyroidism in Diabetic Peripheral Neuropathy
por: Allam MA, et al.
Publicado: (2021) -
Prevalence of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus at a tertiary referral centre in Singapore
por: Arnold Hu Hanquan, et al.
Publicado: (2021) -
The Application of Exercise Training for Diabetic Peripheral Neuropathy
por: Clifton J. Holmes, et al.
Publicado: (2021) -
Diabetic Peripheral Neuropathies: A Morphometric Overview
por: Fazan,Valéria Paula Sassoli, et al.
Publicado: (2010) -
Electrodiagnostics or Ultrasound for Diagnosing Diabetic Peripheral Neuropathy [Letter]
por: Hernandez Fustes OJ, et al.
Publicado: (2021)